In the third quarter of 2021, Frost & Sullivan conducted an analysis of the competitive landscape and development drivers of China's cell therapy industry, reflecting global and Chinese pharmaceutical R&D investment, application areas of cell therapies, and industry development trends over the past few years as well as into the future. The report aims to analyze the current development status, industry characteristics, treatment areas, driving factors, and development trends of China's cell therapy industry, focusing on the market competition situation in the industry. Frost & Sullivan hereby releases the 'White Paper on the Development of China's Cell Therapy Industry'. The analysis of the cell therapy industry provided in this market report also reflects the overall trend of China's cell therapy industry. The analysis of industry characteristics and competitive landscape in the report is only applicable to the development cycle of China's cell therapy industry for the current year.
